Peddock Capital Advisors LLC bought a new position in shares of Amrize Ltd (NYSE:AMRZ – Free Report) during the third quarter, HoldingsChannel.com reports. The firm bought 10,089 shares of the company’s stock, valued at approximately $490,000.
Several other large investors have also added to or reduced their stakes in the company. BNP Paribas Financial Markets bought a new position in shares of Amrize in the second quarter worth approximately $59,000. Groupe la Francaise bought a new stake in shares of Amrize during the 2nd quarter valued at $60,000. Allianz SE purchased a new position in shares of Amrize during the 2nd quarter valued at $80,000. Osaic Holdings Inc. bought a new position in Amrize in the 2nd quarter worth $90,000. Finally, Credit Industriel ET Commercial bought a new position in Amrize in the 2nd quarter worth $109,000.
Amrize Trading Down 0.3%
Shares of AMRZ stock opened at $55.69 on Friday. The company has a quick ratio of 0.85, a current ratio of 1.38 and a debt-to-equity ratio of 0.42. The company has a market capitalization of $30.80 billion and a PE ratio of 30.27. Amrize Ltd has a 12-month low of $44.12 and a 12-month high of $56.76. The stock has a 50-day moving average price of $51.60.
Wall Street Analysts Forecast Growth
Several equities analysts have recently commented on the company. Vertical Research started coverage on Amrize in a research report on Tuesday, November 25th. They issued a “hold” rating and a $54.00 price objective on the stock. Zacks Research raised Amrize from a “strong sell” rating to a “hold” rating in a research note on Friday, October 10th. Royal Bank Of Canada cut Amrize from an “outperform” rating to a “sector perform” rating and boosted their price target for the stock from $56.00 to $60.00 in a report on Monday, December 8th. Weiss Ratings restated a “hold (c+)” rating on shares of Amrize in a research note on Tuesday. Finally, Citigroup lifted their price objective on shares of Amrize from $60.00 to $63.00 and gave the company a “buy” rating in a research report on Monday, November 3rd. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and seven have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $60.00.
View Our Latest Analysis on AMRZ
Insider Transactions at Amrize
In other Amrize news, insider Jaime Hill bought 4,000 shares of the business’s stock in a transaction that occurred on Tuesday, November 4th. The stock was purchased at an average cost of $50.69 per share, with a total value of $202,760.00. Following the completion of the acquisition, the insider owned 18,101 shares in the company, valued at $917,539.69. This trade represents a 28.37% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Nicholas C. Gangestad purchased 2,000 shares of Amrize stock in a transaction that occurred on Wednesday, November 19th. The stock was acquired at an average price of $47.34 per share, for a total transaction of $94,680.00. Following the transaction, the director directly owned 4,958 shares of the company’s stock, valued at $234,711.72. The trade was a 67.61% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have bought a total of 65,000 shares of company stock valued at $3,399,720 over the last quarter.
About Amrize
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
See Also
- Five stocks we like better than Amrize
- Wall Street Stockpicker Names #1 Stock of 2026
- The Best $1 You’ll Spend This Holiday Season
- ALERT: Drop these 5 stocks before January 2026!
- The $650 Million Bet on AI’s Future
- Nvidia x 1,000,000
Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZ – Free Report).
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
